Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...

Ghrelin is the “hunger hormone.” On binding with the ghrelin receptor, MK-677 stimulates the pituitary gland to release GH.

Doctors explain the real symptoms, causes and health risks, plus what testing and treatment actually look like ...

Hot flashes, a common menopausal symptom, can be managed with non-hormonal strategies. Organic soy, rich in isoflavones, and ...

The "Companion Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has ...

WESTWOOD, LOS ANGELES (KABC) -- New UCLA research underscores the importance of hormone replacement therapy (HRT) when it comes to women's brains as they age. Last month, the Food and Drug ...

Abemaciclib is the first CDK4/6 inhibitor to produce a significant overall survival benefit in patients with hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer, ...

Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become ...

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will present a wide range of new breast cancer research at the 2025 San ...

Ascendis Pharma’s strong Q3 2025 revenue and innovative therapies drive growth and profitability. Click here to read an ...